2. INTRODUCTION
• What is hyperlipidemia?
• A condition in which there are high levels of
fat particles(lipids) deposited in the blood.
• Elevated plasma levels of lipids are deposited in the form of
lipoproteins.
Eg: lipids like cholesterol and triglycerides.
• These lipids can deposit in blood vessel walls and restrict blood flow.
• This creates a risk of heart attack & stroke.
5. ANTIHYPERLIPIDEMICS
• The clinically important lipoproteins are HDL,LDL and
VLDL .
• Antihyperlipidemics are the drugs used to reduce the
deposited levels of cholesterol and other lipoproteins from
the blood plasma .
17. MECHANISMS
• Lovastatin regulates cholesterol synthesis in the liver by
inhibiting microsomal reduction of 3-hydroxy 3-methyl
glutaryl CoA (HMG Co A) catalyzed by HMGCoA reductase.
• Colestyramine & Colestepol – The reduction in the amounts
of reabsorbed bile acids results in increased catabolism of
cholesterol in bile acids in the liver.Then it decreases
concentration of bile acids.
18. • Fibrates inhibit triglyceride synthesis ,reduces VLDL release
into circulation.This drug increases lipoprotein lipase
activity,which catabolises the chylomicrons and VLDL.
19. • Probucol lowers the levels of cholesterol in the blood by
increasing the rate of LDL catabolism.Probucol is a powerful
antioxidant which inhibits the oxidation of cholesterol.
• Nicotinic acid and Nicotinamide inhibits a hormone-
sensitive lipase in adipose tissue which reduces the
breakdown of triglycerides to free fatty acids,and the
transport of free fatty acids to the liver.
• Ezetimibe reduces blood cholesterol by inhibiting the
absorption of cholesterol by the small intestine.